東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Self-Encapsulation of Vaccine Antige...

Mazzara, John Maxwell.

FindBook

Google Book

Amazon

博客來

Self-Encapsulation of Vaccine Antigens in PLGA Microparticles and Microneedles.

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Self-Encapsulation of Vaccine Antigens in PLGA Microparticles and Microneedles./
作者:	Mazzara, John Maxwell.
出版者:	Ann Arbor : ProQuest Dissertations & Theses, : 2016,
面頁冊數:	188 p.
附註:	Source: Dissertation Abstracts International, Volume: 78-07(E), Section: B.
Contained By:	Dissertation Abstracts International78-07B(E).
標題:	Pharmaceutical sciences. -
電子資源:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=10391684
ISBN:	9781369588941

Self-Encapsulation of Vaccine Antigens in PLGA Microparticles and Microneedles.
Mazzara, John Maxwell.

Self-Encapsulation of Vaccine Antigens in PLGA Microparticles and Microneedles. - Ann Arbor : ProQuest Dissertations & Theses, 2016 - 188 p.

Source: Dissertation Abstracts International, Volume: 78-07(E), Section: B.

Thesis (Ph.D.)--University of Michigan, 2016.

There is an urgent need to reduce reliance on hypodermic injections for many protein-based therapies. Alternative approaches include developing controlled release formulations, which reduce dosing frequencies, and utilizing alternative delivery devices, such as microneedles. This thesis explores the development of controlled release microparticles made of poly(lactic- co-glycolic acid) (PLGA) that encapsulate stable/active proteins. These microparticles are then delivered via novel microneedle patches. This work has great implications for improving the utility and coverage of protein-based vaccines.

ISBN: 9781369588941Subjects--Topical Terms:

3173021
Pharmaceutical sciences.

Self-Encapsulation of Vaccine Antigens in PLGA Microparticles and Microneedles.
LDR:03568nmm a2200337 4500 001 2157449
005 20180605073451.5
008 190424s2016 ||||||||||||||||| ||eng d
020 $a 9781369588941
035 $a (MiAaPQ)AAI10391684
035 $a (MiAaPQ)umichrackham:000400
035 $a AAI10391684
040 $a MiAaPQ $c MiAaPQ
100 1 $a Mazzara, John Maxwell. $3 3345261
245 1 0 $a Self-Encapsulation of Vaccine Antigens in PLGA Microparticles and Microneedles.
260 1 $a Ann Arbor : $b ProQuest Dissertations & Theses, $c 2016
300 $a 188 p.
500 $a Source: Dissertation Abstracts International, Volume: 78-07(E), Section: B.
500 $a Adviser: Steven P. Schwendeman.
502 $a Thesis (Ph.D.)--University of Michigan, 2016.
520 $a There is an urgent need to reduce reliance on hypodermic injections for many protein-based therapies. Alternative approaches include developing controlled release formulations, which reduce dosing frequencies, and utilizing alternative delivery devices, such as microneedles. This thesis explores the development of controlled release microparticles made of poly(lactic- co-glycolic acid) (PLGA) that encapsulate stable/active proteins. These microparticles are then delivered via novel microneedle patches. This work has great implications for improving the utility and coverage of protein-based vaccines.
520 $a PLGA microparticles are loaded with protein through a novel approach termed active self-healing encapsulation (ASE). This method loads proteins after microparticle fabrication, thus preventing protein exposure to a variety of stresses. ASE utilizes a protein trapping agent (Alhydrogel), along with the self-healing of microparticle surface pores to sequester and trap proteins inside the microparticles. The self-healing phenomenon was explored in detail, and was determined to be a viscoelastic response of the polymer to high surface tension when above the glass-transition temperature (Tg). The healing kinetics followed expected Williams-Landel-Ferry behavior, and Arrhenius plots generated activation energies consistent with polymeric creep. A mathematical model to predict healing times is also presented.
520 $a The ASE technique afforded high loading (1.64% w/w) and encapsulation efficiencies up to 91% for the model protein Ovalbumin. In vitro controlled release was shown to be biphasic, with an initial release of soluble protein followed by a delayed release of Alhydrogel-complexed protein over the course of two months. Furthermore, a bulk batch of microparticles can be used to load many different proteins without needing to reformulate unique batches.
520 $a A process was also designed to deliver protein-loaded microparticles via a microneedle patch. Microneedle patches can be easily self-applied, are easy to store/dispose, and are generally preferred by patients over traditional hypodermic needles. These patches, made of a dissolvable material, successfully delivered microparticles intradermally where they began antigen release. In animal models these patches generated a robust immune response that was as good as or better than conventional administration techniques.
520 $a This thesis lays the ground work for a versatile system for delivering protein-based vaccines with reduced dosing requirements or limited need for hypodermic injections.
590 $a School code: 0127.
650 4 $a Pharmaceutical sciences. $3 3173021
690 $a 0572
710 2 $a University of Michigan. $b Pharmaceutical Sciences. $3 3345262
773 0 $t Dissertation Abstracts International $g 78-07B(E).
790 $a 0127
791 $a Ph.D.
792 $a 2016
793 $a English
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=10391684